All lobbying filings
Stumptown Strategies
Stumptown Strategies filed a Q2 report for Prime Therapeutics on July 21, 2025, reporting $20,000 in lobbying income.
Lobbying for Prime Therapeutics · Healthcare
Filing · LD-2 quarterly report
Q2 report
Reporting period
2nd Quarter 2025
Apr 1 - June 30 · Posted Jul 21, 2025
Income
$20,000
What the client paid this registrant for the period.
Client based in
Minnesota
Lobbyists on this filing
1
-
BLAIR LARKINSPreviously held: Staff Assistant, Greg Walden 2005-2006, Executive Assistant, Greg Walden 2006-2001
Government bodies contacted
2
Lobbying activity
2
PBM issues - Transparency, Delinking HR 2214 Drug Act
HR 2214 DRUG Act Delinking, PBM Issues
Bills named in this filing
1